New brain vaccine aims to turn fatal disease into chronic ones.

In this article scientists are trying to change brain tumors, or brain cancer, from a fatal killer to a manageable disease. Today the five year survival rate for brain cancer is 1%, the University of Miami and nine other institutes are trying to end the tumor’s fatal reputation through clinical experiments. The new vaccine is given quickly after a patient’s diagnosis with glioblastomas. Chemotherapy, radiation and other treatments are then stopped. Glioblastomas are the most devastating tumor and account for 30 percent of all brain tumors. So far the clinical vaccine is in Phase I of the trial with 10 patients, with hope to soon move onto Phase II, which with more patients could hopefully result in the FDA approval.

Do you think cancer patients should shop treatments to thy this experimental vaccine?